PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Alkem Laboratories Limited (ALKEM.NS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISININE540L01014
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market Cap₹621.14B
EPS₹131.81
PE Ratio39.41
PEG Ratio-1,057.29
Revenue (TTM)₹126.34B
Gross Profit (TTM)₹65.79B
EBITDA (TTM)₹21.93B
Year Range₹3,157.64 - ₹5,520.00
Target Price₹4,853.96

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Alkem Laboratories Limited

Performance

Performance Chart

The chart shows the growth of an initial investment of ₹10,000 in Alkem Laboratories Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%250.00%300.00%December2024FebruaryMarchAprilMay
315.71%
224.33%
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

S&P 500

Returns By Period

Alkem Laboratories Limited had a return of 2.90% year-to-date (YTD) and 58.58% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date2.90%11.05%
1 month12.33%4.86%
6 months22.75%17.50%
1 year58.58%27.37%
5 years (annualized)27.61%13.14%
10 years (annualized)N/A10.90%

Monthly Returns

The table below presents the monthly returns of ALKEM.NS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-3.97%3.31%-3.61%-2.20%2.90%
20230.22%6.24%6.96%3.35%-4.28%4.56%13.26%-8.22%-1.01%3.22%26.91%10.14%74.89%
2022-2.34%-6.58%10.46%-10.23%-3.12%-4.78%7.56%-7.65%10.17%-3.72%-0.98%-3.82%-16.27%
20212.76%-8.68%1.75%-0.39%8.34%7.03%7.95%12.47%2.63%-9.30%-0.48%0.85%25.11%
202019.06%10.42%-11.41%11.76%-12.95%4.66%12.41%2.38%2.03%-5.17%7.87%2.98%46.67%
2019-3.39%-6.99%-0.12%-1.34%4.42%-6.99%4.37%4.82%4.81%4.86%1.57%-0.75%4.25%
2018-0.14%1.54%-10.69%-0.60%-3.01%-1.34%12.05%0.13%-2.83%-7.21%0.30%1.91%-10.93%
20172.44%28.36%2.96%-10.59%-2.02%-3.93%-1.27%-1.23%2.24%1.80%6.05%10.81%35.89%
2016-8.51%-6.93%8.03%-12.20%6.08%9.58%13.17%-1.21%7.33%-1.77%4.54%-4.19%10.84%
20157.49%7.49%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of ALKEM.NS is 88, placing it in the top 12% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ALKEM.NS is 8888
ALKEM.NS (Alkem Laboratories Limited)
The Sharpe Ratio Rank of ALKEM.NS is 9090Sharpe Ratio Rank
The Sortino Ratio Rank of ALKEM.NS is 8686Sortino Ratio Rank
The Omega Ratio Rank of ALKEM.NS is 8686Omega Ratio Rank
The Calmar Ratio Rank of ALKEM.NS is 9494Calmar Ratio Rank
The Martin Ratio Rank of ALKEM.NS is 8282Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Alkem Laboratories Limited (ALKEM.NS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ALKEM.NS
Sharpe ratio
The chart of Sharpe ratio for ALKEM.NS, currently valued at 1.89, compared to the broader market-2.00-1.000.001.002.003.004.001.89
Sortino ratio
The chart of Sortino ratio for ALKEM.NS, currently valued at 2.60, compared to the broader market-4.00-2.000.002.004.006.002.60
Omega ratio
The chart of Omega ratio for ALKEM.NS, currently valued at 1.34, compared to the broader market0.501.001.502.001.34
Calmar ratio
The chart of Calmar ratio for ALKEM.NS, currently valued at 2.65, compared to the broader market0.002.004.006.002.65
Martin ratio
The chart of Martin ratio for ALKEM.NS, currently valued at 5.70, compared to the broader market-10.000.0010.0020.0030.005.70
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.49, compared to the broader market-2.00-1.000.001.002.003.004.002.49
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.006.003.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.43, compared to the broader market0.501.001.502.001.43
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.03, compared to the broader market0.002.004.006.002.03
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.57, compared to the broader market-10.000.0010.0020.0030.009.57

Sharpe Ratio

The current Alkem Laboratories Limited Sharpe ratio is 1.89. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Alkem Laboratories Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50December2024FebruaryMarchAprilMay
1.89
2.72
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

Dividends

Dividend History

Alkem Laboratories Limited granted a 0.85% dividend yield in the last twelve months. The annual payout for that period amounted to ₹45.00 per share.


PeriodTTM20232022202120202019201820172016
Dividend₹45.00₹35.00₹34.00₹30.00₹25.00₹16.00₹13.00₹9.00₹15.70

Dividend yield

0.85%0.67%1.13%0.83%0.85%0.79%0.67%0.41%0.96%

Monthly Dividends

The table displays the monthly dividend distributions for Alkem Laboratories Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024₹0.00₹35.00₹0.00₹0.00₹0.00₹35.00
2023₹0.00₹25.00₹0.00₹0.00₹0.00₹0.00₹0.00₹10.00₹0.00₹0.00₹0.00₹0.00₹35.00
2022₹0.00₹30.00₹0.00₹0.00₹0.00₹0.00₹0.00₹4.00₹0.00₹0.00₹0.00₹0.00₹34.00
2021₹0.00₹25.00₹0.00₹0.00₹0.00₹0.00₹0.00₹5.00₹0.00₹0.00₹0.00₹0.00₹30.00
2020₹0.00₹22.00₹0.00₹0.00₹0.00₹0.00₹0.00₹3.00₹0.00₹0.00₹0.00₹0.00₹25.00
2019₹0.00₹8.00₹0.00₹0.00₹0.00₹0.00₹0.00₹8.00₹0.00₹0.00₹0.00₹0.00₹16.00
2018₹0.00₹6.00₹0.00₹0.00₹0.00₹0.00₹0.00₹7.00₹0.00₹0.00₹0.00₹0.00₹13.00
2017₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹9.00₹0.00₹0.00₹0.00₹0.00₹9.00
2016₹9.70₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹6.00₹0.00₹15.70

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%0.9%
Alkem Laboratories Limited has a dividend yield of 0.85%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%44.3%
Alkem Laboratories Limited has a payout ratio of 44.27%, which is quite average when compared to the overall market. This suggests that Alkem Laboratories Limited strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-2.81%
-0.15%
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Alkem Laboratories Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alkem Laboratories Limited was 27.40%, occurring on Jun 28, 2019. Recovery took 132 trading sessions.

The current Alkem Laboratories Limited drawdown is 2.81%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-27.4%Jan 11, 2018358Jun 28, 2019132Jan 13, 2020490
-26.86%Sep 27, 2021158May 17, 2022296Jul 25, 2023454
-23.77%Jan 6, 201686May 13, 201649Jul 22, 2016135
-22.86%Mar 28, 201795Aug 11, 201795Dec 29, 2017190
-18.53%Apr 28, 202022May 29, 202046Aug 3, 202068

Volatility

Volatility Chart

The current Alkem Laboratories Limited volatility is 7.91%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%December2024FebruaryMarchAprilMay
7.91%
3.45%
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alkem Laboratories Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items